Top

International Urogynecology Journal

Published in:

01-03-2010 | Original Article

Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity

Authors: Michael L. Guralnick, Gwen Grimsby, Michael Liss, Aniko Szabo, R. Corey O’Connor

Published in: International Urogynecology Journal | Issue 3/2010

Abstract

Introduction and hypothesis

This paper aims to determine if there are differences between female overactive bladder (OAB) patients with and without urodynamic detrusor overactivity (DO).

Methods

A retrospective chart review was performed on 146 women with OAB. All patients completed an American Urological Association symptom score, 48-h bladder diary (documenting voided volumes, incontinent episodes, and degree of urgency to void), and urodynamic testing (UDS). Patients with urodynamic DO were then compared to patients without DO.

Results

There were no differences in symptom scores. Patients with DO (54.1%) were older (61.8 vs. 50.8 years) and had smaller maximum voided volumes per void (377 mL vs. 476 mL), average 24-h urine output (1,975 mL vs. 2,320 mL), and significantly more incontinent episodes. On UDS, patients with DO were more likely to have abnormal sensation, with strong desire and urgency occurring at significantly lower bladder volumes.

Conclusion

Despite similar symptomatology, there are objective differences between OAB patients with and without DO.

Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21:167–178CrossRefPubMed

Haylen BT, Chetty N, Logan V et al (2007) Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol J Pelvic Floor Dysfunct 18:123–128PubMed

Radley SC, Rosario DJ, Chapple CR et al (2001) Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol 166:2253–2258CrossRefPubMed

Naoemova I, De Wachter S, Wuyts FL et al (2008) Do sensation-related bladder diaries differ between patients with urodynamically confirmed and non-objectivised urinary incontinence? Int Urogynecol J Pelvic Floor Dysfunct 19:213–216CrossRefPubMed

Nixon A, Colman S, Sabounjian L et al (2005) A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 174:604–607CrossRefPubMed

De Wachter S, Wyndaele JJ (2008) How sudden is a compelling desire to void? An observational cystometric study on the suddenness of this sensation. BJU Int 101:1000–1003CrossRefPubMed

Digesu GA, Khullar V, Cardozo L et al (2003) Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 22:105–108CrossRefPubMed

Hashim H, Abrams P (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175:191–194 discussion 194–195CrossRefPubMed

Naoemova I, De Wachter S, Wuyts FL et al (2008) Reliability of the 24-h sensation-related bladder diary in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:955–959CrossRefPubMed

10.

Wyndaele JJ (1993) Is impaired perception of bladder filling during cystometry a sign of neuropathy? Br J Urol 71:270–273CrossRefPubMed

11.

Klein LA (1988) Urge incontinence can be a disease of bladder sensors. J Urol 139:1010–1014PubMed

12.

Malone-Lee J, Henshaw DJ, Cummings K (2003) Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int 92:415–417CrossRefPubMed

13.

Malone-Lee JG, Al-Buheissi S (2009) Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study. BJU Int 103:931–937CrossRefPubMed

14.

South MM, Romero AA, Jamison MG et al (2007) Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation. Int Urogynecol J Pelvic Floor Dysfunct 18:1395–1398CrossRefPubMed

15.

Dmochowski R, Sand PK (2007) Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int 99:247–262CrossRefPubMed

16.

Schulte-Baukloh H, Weiss C, Stolze T et al (2005) Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66:82–87CrossRefPubMed

17.

Romanzi LJ, Chaikin DC, Blaivas JG (1999) The effect of genital prolapse on voiding. J Urol 161:581–586CrossRefPubMed

Title: Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity
Authors: Michael L. Guralnick
Gwen Grimsby
Michael Liss
Aniko Szabo
R. Corey O’Connor
Publication date: 01-03-2010
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 3/2010
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-009-1030-7

At a glance: The STEP trials

Springer Medicine

Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2010

Factors used by female pelvic medicine and reconstructive surgery fellowship directors to select their fellows

Polypropylene as a reinforcement in pelvic surgery is not inert: comparative analysis of 100 explants

A case report of antepartum bladder outlet obstruction following transobturator sling placement

Use of a beef tongue model and instructional video for teaching residents fourth-degree laceration repair

Preoperative urethral parameters at rest and objective cure following laparoscopic colposuspension

Laser excision of encrusted intra-vesical tension-free vaginal tape (TVT)